科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/08/16 | 1,126 | 1,132 | 1,117 | 1,120 | -6 | -0.5% | 238,000 |
| 2012/08/15 | 1,126 | 1,127 | 1,120 | 1,126 | ±0 | ±0% | 60,000 |
| 2012/08/14 | 1,107 | 1,129 | 1,105 | 1,126 | +19 | +1.7% | 175,000 |
| 2012/08/13 | 1,107 | 1,114 | 1,106 | 1,107 | -4 | -0.4% | 117,000 |
| 2012/08/10 | 1,114 | 1,117 | 1,103 | 1,111 | -3 | -0.3% | 130,000 |
| 2012/08/09 | 1,110 | 1,117 | 1,101 | 1,114 | +11 | +1% | 324,000 |
| 2012/08/08 | 1,104 | 1,111 | 1,099 | 1,103 | +3 | +0.3% | 244,000 |
| 2012/08/07 | 1,096 | 1,105 | 1,091 | 1,100 | +4 | +0.4% | 275,000 |
| 2012/08/06 | 1,080 | 1,097 | 1,079 | 1,096 | +19 | +1.8% | 227,000 |
| 2012/08/03 | 1,110 | 1,118 | 1,076 | 1,077 | -48 | -4.3% | 251,000 |
| 2012/08/02 | 1,113 | 1,132 | 1,113 | 1,125 | +12 | +1.1% | 242,000 |
| 2012/08/01 | 1,101 | 1,114 | 1,101 | 1,113 | +2 | +0.2% | 182,000 |
| 2012/07/31 | 1,110 | 1,118 | 1,105 | 1,111 | ±0 | ±0% | 151,000 |
| 2012/07/30 | 1,105 | 1,111 | 1,096 | 1,111 | +9 | +0.8% | 132,000 |
| 2012/07/27 | 1,113 | 1,114 | 1,098 | 1,102 | -10 | -0.9% | 78,000 |
| 2012/07/26 | 1,113 | 1,114 | 1,096 | 1,112 | +6 | +0.5% | 238,000 |
| 2012/07/25 | 1,101 | 1,117 | 1,096 | 1,106 | +1 | +0.1% | 202,000 |
| 2012/07/24 | 1,110 | 1,117 | 1,101 | 1,105 | ±0 | ±0% | 303,000 |
| 2012/07/23 | 1,111 | 1,124 | 1,105 | 1,105 | -17 | -1.5% | 179,000 |
| 2012/07/20 | 1,148 | 1,148 | 1,120 | 1,122 | -25 | -2.2% | 262,000 |
| 2012/07/19 | 1,140 | 1,148 | 1,135 | 1,147 | +14 | +1.2% | 213,000 |
| 2012/07/18 | 1,140 | 1,148 | 1,129 | 1,133 | ±0 | ±0% | 264,000 |
| 2012/07/17 | 1,129 | 1,138 | 1,125 | 1,133 | +4 | +0.4% | 245,000 |
| 2012/07/13 | 1,121 | 1,135 | 1,121 | 1,129 | +9 | +0.8% | 208,000 |
| 2012/07/12 | 1,116 | 1,126 | 1,111 | 1,120 | +2 | +0.2% | 193,000 |
| 2012/07/11 | 1,132 | 1,132 | 1,112 | 1,118 | -11 | -1% | 314,000 |
| 2012/07/10 | 1,120 | 1,131 | 1,116 | 1,129 | +10 | +0.9% | 266,000 |
| 2012/07/09 | 1,102 | 1,121 | 1,102 | 1,119 | +12 | +1.1% | 133,000 |
| 2012/07/06 | 1,129 | 1,129 | 1,101 | 1,107 | -21 | -1.9% | 199,000 |
| 2012/07/05 | 1,140 | 1,141 | 1,124 | 1,128 | +2 | +0.2% | 209,000 |
| 2012/07/04 | 1,133 | 1,133 | 1,122 | 1,126 | -5 | -0.4% | 234,000 |
| 2012/07/03 | 1,112 | 1,131 | 1,112 | 1,131 | +20 | +1.8% | 252,000 |
| 2012/07/02 | 1,124 | 1,127 | 1,111 | 1,111 | -7 | -0.6% | 202,000 |
| 2012/06/29 | 1,096 | 1,122 | 1,096 | 1,118 | +15 | +1.4% | 246,000 |
| 2012/06/28 | 1,093 | 1,107 | 1,093 | 1,103 | +5 | +0.5% | 241,000 |
| 2012/06/27 | 1,090 | 1,098 | 1,085 | 1,098 | +10 | +0.9% | 190,000 |
| 2012/06/26 | 1,086 | 1,106 | 1,086 | 1,088 | -3 | -0.3% | 297,000 |
| 2012/06/25 | 1,086 | 1,098 | 1,086 | 1,091 | -5 | -0.5% | 195,000 |
| 2012/06/22 | 1,082 | 1,099 | 1,078 | 1,096 | +10 | +0.9% | 321,000 |
| 2012/06/21 | 1,078 | 1,087 | 1,075 | 1,086 | +8 | +0.7% | 392,000 |
| 2012/06/20 | 1,080 | 1,085 | 1,077 | 1,078 | +15 | +1.4% | 322,000 |
| 2012/06/19 | 1,062 | 1,072 | 1,058 | 1,063 | +12 | +1.1% | 415,000 |
| 2012/06/18 | 1,048 | 1,056 | 1,048 | 1,051 | +10 | +1% | 285,000 |
| 2012/06/15 | 1,014 | 1,049 | 1,014 | 1,041 | +28 | +2.8% | 552,000 |
| 2012/06/14 | 1,031 | 1,033 | 1,011 | 1,013 | -18 | -1.7% | 327,000 |
| 2012/06/13 | 1,030 | 1,038 | 1,030 | 1,031 | +2 | +0.2% | 158,000 |
| 2012/06/12 | 1,026 | 1,032 | 1,019 | 1,029 | +3 | +0.3% | 209,000 |
| 2012/06/11 | 1,039 | 1,039 | 1,025 | 1,026 | -11 | -1.1% | 204,000 |
| 2012/06/08 | 1,042 | 1,042 | 1,029 | 1,037 | -3 | -0.3% | 232,000 |
| 2012/06/07 | 1,030 | 1,043 | 1,025 | 1,040 | +10 | +1% | 203,000 |
3101～
3150
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
